Medical enhance株式会社,相﨑貴子ヨガ

We have been developing outsourcing platforms, IT solutions in the medical and healthcare fields. The experience we have gained in professional nursing and long-term clinical trial coordinating combined with the experience of communicating with over 70,000 customers in yoga teaching is essential to our support.
We believe we can improve the QOL ( quality of life: improving the quality of each person’s life and social life) digitally with great engineers that support the use of utilities and increase the reliability of “observe compliance” in the healthcare field.

We hope to continue to support you.
Thank you very much.

Click here. Blogger
https://m-enhance.blogspot.com/

Director Kiko Aizaki

  • as a Medical & health care social digital developer
  • as a CRC/clinical research coordinator
  • as a yoga instructor /Enhance-yoga method creator, 70,000 customers as a “yoga instructor” in the healthcare field, Repeat rate 90% of customers.

Background

18 years’ experience in the clinical field as a nurse at the Aichi Medical University Hospital and Aichi Cancer Center, among others, before advancing my career to become a CRC (l Clinical Research Coordinator) in 2006.

Experience as an Interpreter

As an interpreter

English interpreting for the training of foreign nurses in medical institutions. English interpreting for inpatients; pre-operative, post-operative and discharge instructions for patients from overseas.
I also have experience as a foreign teacher’s assistant.

Experience as a Clinical Research Coordinator. The following is the number of cases handled. (No GCP violations or major deviations occurred)

  • Consulting experience: over 228 cases
  • Case history: over 206 cases

Unplecedented Audit
Medical institution,Site manegement organization demanded Audit to Sponcer.

  • Acute otitis media and acute sinusitis in children Phase III
  • Dry eye dose-response validation study Phase II
  • Double-blind comparative study of ophthalmic ointments for dry eyes (1st semester) Phase II exploratory study
  • Phase III study of inflammation and eye pain after ophthalmic surgery
  • Prevention of cystoid macular edema after lens reconstruction and intraocular lens implantation double-shielding study
    ※Manufacturer’s audit, site survey. The results of the audit investigation are clear.
  • Low-dose pill EE dose confirmation and long-term safety study Phase II/III
  • A placebo-controlled, double-blind, parallel-group study for major depressive disorder.
  • Long-term studies for major depressive disorder
  • A randomized, double-blind, placebo-controlled study of adult outpatients with major depressive disorder
  • Schizophrenia: clinical trials/abandonment rates, remission rates and long-term studies of social functioning.
  • Pediatric/Safety: Efficacy and pharmacokinetics, multi-center, open-label, controlled study Phase III
    ※Coordination of subjects under ICU supervision in SAE.
  • Orthopedics/Safety and Efficacy, Long-Term Safety Phase III
  • A placebo-controlled, double-blind, validated trial in psychiatry/schizophrenia Phase III
  • A long-term study in psychiatric/schizophrenia Phase III
  • A validation study in psychiatric/schizophrenia patients.
  • Psychiatry/validated and continuing long-term studies
  • Psychiatric/placebo-controlled, double-blind, parallel-group studies
  • Psychiatry/long term administration, safety and efficacy
That’s all sincerely